Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Faster, Cleaner, Better.

Biocorrx Inc New (BICX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2025	12-2024	12-2023	12-2022	12-2021
Cash Flows From Operating Activities
Net Income	-3,509	-5,212	-3,771	-4,377	-5,211
Depreciation Amortization	617	1,197	844	637	646
Accounts receivable	-254	1	35	-34	-1
Other Working Capital	-515	1,523	714	578	704
Other Operating Activity	1,361	1,395	325	1,155	324
Operating Cash Flow	$-2,298	$-1,096	$-1,853	$-2,042	$-3,538

Cash Flows From Investing Activities
PPE Investments	N/A	N/A	N/A	N/A	-2
Purchase Sale Intangibles	N/A	N/A	N/A	N/A	-48
Other Investing Activity	0	0	0	0	-48
Investing Cash Flow	$N/A	$N/A	$N/A	$N/A	$-50

Cash Flows From Financing Activities
Debt Issued	1,148	1,132	971	775	831
Debt Repayment	-677	-12	-35	N/A	N/A
Common Stock Issued	1,879	N/A	915	1,250	2,250
Other Financing Activity	0	0	-1	0	0
Financing Cash Flow	$2,350	$1,119	$1,850	$2,025	$3,081

Beginning Cash Position	88	65	69	86	592
End Cash Position	139	88	65	69	86
Net Cash Flow	$51	$23	$-3	$-17	$-506

Free Cash Flow
Operating Cash Flow	-2,298	-1,096	-1,853	-2,042	-3,538
Capital Expenditure	N/A	N/A	N/A	N/A	-2
Free Cash Flow	-2,298	-1,096	-1,853	-2,042	-3,540